190 related articles for article (PubMed ID: 23903573)
1. Immunotherapy exposes cancer stem cell resistance and a new synthetic lethality.
Radvanyi L
Mol Ther; 2013 Aug; 21(8):1472-4. PubMed ID: 23903573
[No Abstract] [Full Text] [Related]
2. A new era for cancer immunotherapy based on the genes that encode cancer antigens.
Rosenberg SA
Immunity; 1999 Mar; 10(3):281-7. PubMed ID: 10204484
[No Abstract] [Full Text] [Related]
3. Teaching the immune system to fight cancer.
Boon T
Sci Am; 1993 Mar; 268(3):82-9. PubMed ID: 8316825
[No Abstract] [Full Text] [Related]
4. Cancer is a somatic cell pregnancy.
Old LJ
Cancer Immun; 2007 Nov; 7():19. PubMed ID: 17983204
[No Abstract] [Full Text] [Related]
5. Yeasts encoding tumour antigens in cancer immunotherapy.
Franzusoff A; Duke RC; King TH; Lu Y; Rodell TC
Expert Opin Biol Ther; 2005 Apr; 5(4):565-75. PubMed ID: 15934834
[TBL] [Abstract][Full Text] [Related]
6. Human tumor immunology at the molecular divide.
Finn OJ
J Immunol; 2007 Mar; 178(5):2615-6. PubMed ID: 17312098
[No Abstract] [Full Text] [Related]
7. Rekindling cancer vaccines.
Branca MA
Nat Biotechnol; 2016 Oct; 34(10):1019-1024. PubMed ID: 27727216
[No Abstract] [Full Text] [Related]
8. [NY-ESO-1 and cancer immunotherapy].
Peng JR; Leng XS
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2008 Aug; 30(4):371-7. PubMed ID: 18795604
[TBL] [Abstract][Full Text] [Related]
9. Genomic prediction of neoantigens: immunogenomics before NGS.
Mardis ER
Nat Rev Genet; 2021 Sep; 22(9):550-551. PubMed ID: 33990775
[No Abstract] [Full Text] [Related]
10. [RNA-loaded dendritic cells].
Hinoda Y
Nihon Rinsho; 2005 Apr; 63 Suppl 4():613-8. PubMed ID: 15861719
[No Abstract] [Full Text] [Related]
11. New paths in human cancer serology.
Old LJ; Chen YT
J Exp Med; 1998 Apr; 187(8):1163-7. PubMed ID: 9547328
[No Abstract] [Full Text] [Related]
12. Tumor immunology.
Naftzger C; Houghton AN
Curr Opin Oncol; 1991 Feb; 3(1):93-9. PubMed ID: 2043699
[TBL] [Abstract][Full Text] [Related]
13. RNA Technologies Expand Tool Kit for Cancer Immunotherapy.
Cancer Discov; 2019 Oct; 9(10):OF5. PubMed ID: 31409586
[TBL] [Abstract][Full Text] [Related]
14. [Cancer immunotherapy targeting neoantigens derived from tumor-specific gene mutations].
Sasada T
Nihon Rinsho; 2017 Feb; 75(2):189-195. PubMed ID: 30562851
[TBL] [Abstract][Full Text] [Related]
15. Mutational and Antigenic Landscape in Tumor Progression and Cancer Immunotherapy.
Vitale I; Sistigu A; Manic G; Rudqvist NP; Trajanoski Z; Galluzzi L
Trends Cell Biol; 2019 May; 29(5):396-416. PubMed ID: 30765144
[TBL] [Abstract][Full Text] [Related]
16. Tumor immunology.
Stevenson H; Tsang KY
Immunol Ser; 1993; 58():497-515. PubMed ID: 8424991
[No Abstract] [Full Text] [Related]
17. Personalized cancer vaccines.
Jain KK
Expert Opin Biol Ther; 2010 Dec; 10(12):1637-47. PubMed ID: 20979567
[TBL] [Abstract][Full Text] [Related]
18. Regulation of cancer germline antigen gene expression: implications for cancer immunotherapy.
Akers SN; Odunsi K; Karpf AR
Future Oncol; 2010 May; 6(5):717-32. PubMed ID: 20465387
[TBL] [Abstract][Full Text] [Related]
19. Engineering advanced cancer therapies with synthetic biology.
Wu MR; Jusiak B; Lu TK
Nat Rev Cancer; 2019 Apr; 19(4):187-195. PubMed ID: 30837696
[TBL] [Abstract][Full Text] [Related]
20. The potential of melanoma antigen expression in cancer therapy.
Gillespie AM; Coleman RE
Cancer Treat Rev; 1999 Aug; 25(4):219-27. PubMed ID: 10448130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
